Wuhan Thalys Med Tech Co Ltd (603716) — Free Cash Flow Generation Index
Wuhan Thalys Med Tech Co Ltd (603716) has a Free Cash Flow Generation Index of 0.97x as of September 2025. Free cash flow of CN¥53.00 Million represents 1% of operating cash flow (CN¥54.57 Million). Read 603716 total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Wuhan Thalys Med Tech Co Ltd Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Wuhan Thalys Med Tech Co Ltd across 9 annual periods. Explore Wuhan Thalys Med Tech Co Ltd (603716) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Wuhan Thalys Med Tech Co Ltd (2012–2024)
Year-by-year Free Cash Flow Generation Index for Wuhan Thalys Med Tech Co Ltd. For the full company profile including market capitalisation, see Wuhan Thalys Med Tech Co Ltd (603716) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.77x | CN¥76.39 Million | CN¥99.60 Million | CN¥23.21 Million | ▲ +13.5% |
| 2023 | 0.68x | CN¥85.06 Million | CN¥125.89 Million | CN¥40.83 Million | ▲ +171.6% |
| 2022 | -0.94x | CN¥-26.52 Million | CN¥28.12 Million | CN¥54.64 Million | ▲ +92.0% |
| 2020 | -11.84x | CN¥-117.76 Million | CN¥9.94 Million | CN¥127.70 Million | ▼ -43221.6% |
| 2019 | -0.03x | CN¥-2.57 Million | CN¥93.92 Million | CN¥96.49 Million | ▼ -122.4% |
| 2015 | 0.12x | CN¥5.64 Million | CN¥46.11 Million | CN¥40.47 Million | ▲ +320.5% |
| 2014 | -0.06x | CN¥-1.67 Million | CN¥30.07 Million | CN¥31.73 Million | ▲ +0.4% |
| 2013 | -0.06x | CN¥-1.81 Million | CN¥32.54 Million | CN¥34.35 Million | ▲ +99.6% |
| 2012 | -14.20x | CN¥-38.34 Million | CN¥2.70 Million | CN¥41.04 Million | — |